Retracted: Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

BioMed Research International
DOI: https://doi.org/10.1155/2022/9808495
2022-12-26
BioMed Research International
Abstract:BioMed Research International has retracted the article titled "Clinical Efficacy and Safety Analysis of PD-1/PD-L1 Inhibitor vs. Chemotherapy in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis" [1] due to concerns that the peer review process has been compromised.
biotechnology & applied microbiology,medicine, research & experimental
What problem does this paper attempt to address?